Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 4:06 pm Sale |
2021-12-31 | 13G | Neoleukin Therapeutics, Inc. NLTX |
Silva Manzano Daniel Adriano | 145,458 6.800% |
-1,449 (-0.99%) |
Filing History |
| 2022-02-11 4:06 pm Purchase |
2021-12-31 | 13G | Neoleukin Therapeutics, Inc. NLTX |
Ulge Umut | 156,387 7.300% |
9,115 (+6.19%) |
Filing History |
| 2022-02-10 11:10 am Purchase |
2022-02-10 | 13G | Neoleukin Therapeutics, Inc. NLTX |
PICTET ASSET MANAGEMENT SA | 128,714 6.070% |
128,714 (New Position) |
Filing History |
| 2022-02-02 7:18 pm Sale |
2021-12-31 | 13G | Neoleukin Therapeutics, Inc. NLTX |
BlackRock Inc. BLK |
130,232 6.100% |
-4,013 (-2.99%) |
Filing History |
| 2021-02-16 4:10 pm Purchase |
2020-12-31 | 13G | Neoleukin Therapeutics, Inc. NLTX |
Redmile Group LLC | 209,783 9.900% |
209,783 (New Position) |
Filing History |
| 2021-02-16 12:05 pm Sale |
2020-12-31 | 13G | Neoleukin Therapeutics, Inc. NLTX |
EcoR1 Capital LLC | 156,135 7.500% |
-39,659 (-20.26%) |
Filing History |
| 2021-02-12 4:27 pm Sale |
2020-12-31 | 13G | Neoleukin Therapeutics, Inc. NLTX |
Ulge Umut | 147,272 6.980% |
-8,323 (-5.35%) |
Filing History |
| 2021-02-12 4:25 pm Sale |
2020-12-31 | 13G | Neoleukin Therapeutics, Inc. NLTX |
Silva Manzano Daniel Adriano | 146,907 6.960% |
-8,688 (-5.58%) |
Filing History |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | Neoleukin Therapeutics, Inc. NLTX |
BlackRock Inc. BLK |
134,246 6.400% |
134,246 (New Position) |
Filing History |
| 2020-12-23 5:11 pm Purchase |
2020-07-07 | 13D | Neoleukin Therapeutics, Inc. NLTX |
Baker Bros. Advisors LP | 211,491 9.990% |
21,241 (+11.16%) |
Filing History |